The Department of Health (LDH) requested the Managed Care Organizations (MCOs) start a new project that will span six months, ending September 30, 2024, requiring each MCO to thoroughly review and make corrections to their network reporting to eliminate inaccurate or outdated information.
Also in Louisiana, the May 14 issue of Pharmacy Facts announced that beginning July 1, 2024, Louisiana Medicaid is revising the Single Preferred Drug List (PDL), shifting both brand and generic versions of these drugs to preferred status. With the implementation of the new PDL, prescribing providers are advised to note “brand name necessary” on prescriptions where they want to ensure pharmacies fill their prescriptions with brand name drugs. Absent this notation, individual pharmacists will make the decision on whether to fill the prescription with brand or generic drugs. The new PDL will be posted online.
For more information, contact NACDS’ Mary Staples at 817-442-1155.